GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Ortho Clinical Diagnostics Holdings PLC (NAS:OCDX) » Definitions » Tangible Book per Share

Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Tangible Book per Share : $-4.08 (As of Mar. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Ortho Clinical Diagnostics Holdings Tangible Book per Share?

Tangible book value per share is calculated as the total tangible equity divided by Shares Outstanding (EOP). Total tangible equity is calculated as the Total Stockholders Equity minus Preferred Stock minus Intangible Assets. Ortho Clinical Diagnostics Holdings's tangible book value per share for the quarter that ended in Mar. 2022 was $-4.08.

Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


Ortho Clinical Diagnostics Holdings Tangible Book per Share Historical Data

The historical data trend for Ortho Clinical Diagnostics Holdings's Tangible Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortho Clinical Diagnostics Holdings Tangible Book per Share Chart

Ortho Clinical Diagnostics Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21
Tangible Book per Share
- -11.12 -11.31 -12.04 -4.40

Ortho Clinical Diagnostics Holdings Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Tangible Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.04 -4.91 -4.59 -4.40 -4.08

Competitive Comparison of Ortho Clinical Diagnostics Holdings's Tangible Book per Share

For the Diagnostics & Research subindustry, Ortho Clinical Diagnostics Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortho Clinical Diagnostics Holdings's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Ortho Clinical Diagnostics Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ortho Clinical Diagnostics Holdings's Price-to-Tangible-Book falls into.



Ortho Clinical Diagnostics Holdings Tangible Book per Share Calculation

Ortho Clinical Diagnostics Holdings's Tangible Book Value Per Share for the fiscal year that ended in Dec. 2021 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(410.5-0.1-1452.8)/237.204
=-4.39

Ortho Clinical Diagnostics Holdings's Tangible Book Value Per Share for the quarter that ended in Mar. 2022 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(443.3-0.1-1413.5)/237.735
=-4.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


Ortho Clinical Diagnostics Holdings  (NAS:OCDX) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Ortho Clinical Diagnostics Holdings Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of Ortho Clinical Diagnostics Holdings's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1001 Route 202, Raritan, NJ, USA, 08869
Ortho Clinical Diagnostics Holdings PLC offers in vitro diagnostics solutions and services. It provides diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. The company operates through three geographic segments such as Americas, EMEA, Greater China, and Other. Americas segment generates most of the revenue for the firm.
Executives
Robert Clifton Yates director C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Chockalingam Palaniappan officer: Chief Innovation Officer C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Christopher M Smith director, officer: Chairman and CEO 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Michael S. Iskra officer: Executive Vice President C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS, 1001 ROUTE 202, RARITAN NJ 08869
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015
Michael A. Schlesinger officer: EVP, GC and Secretary C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Carlyle Partners Vi Cayman Holdings, L.p. 10 percent owner C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Tc Group Vi Cayman, L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Vi Cayman, L.p. 10 percent owner C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Cg Subsidiary Holdings L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings Sub L.p. 10 percent owner C/O WALKER CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001
Carlyle Holdings Ii L.l.c. 10 percent owner C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Holdings Ii Gp L.l.c. 10 percent owner C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Group Inc. 10 percent owner C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings, L.p. 10 percent owner C/O WALKERS CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001

Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Headlines

From GuruFocus

CRAMER ROSENTHAL MCGLYNN LLC Buys 1, Sells 4 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-14-2022